The Patent Finder
LI

Lipocine Inc.

Filings on record here from 2001, where this site's data begins
OverviewNotableFeesChangesFamiliesPatent listSources & methods

62 patents currently held

Held is read from USPTO's recorded assignments; a transfer never recorded there does not appear.

The next term ends in Jan 2029. from the record

Free plan: 3 watched companies. Pro: unlimited.
Alerts on its grants, lapses and transfers.
17
Ending by 2030
Jan 2029
Next term end
19
Patent families

When these terms end

Held patents by the year their term ends
20262027202820292030203120322033203420352036203720382039204020412042204320442045
notable patents fee due within 90 days all others Updated Nov 15, 2026 · includes USPTO assignment & status data published Nov 15, 2026 and grant & fee data published Nov 10, 2026 (weekly) · how we know
Notable: the highest-ranked patents in this portfolio by citations and family size. Fee due within 90 days: a maintenance fee is due within 90 days of when this page was computed and not yet paid.

Fee deadlines

Maintenance fees fall due 3.5, 7.5 and 11.5 years after grant. A missed fee ends a patent at the end of the six month grace period that follows, not on the due date.
  • 1 fee due Nov 19, 2026
    The maintenance fee for High-Strength Testosterone Undecanoate Compositions (US 9,034,858) comes due Nov 19, 2026. Unpaid by May 19, 2027, it lapses early.
  • 1 fee due Dec 13, 2026
    The maintenance fee for Oral Testosterone Non-Undecanoate Therapy (US 11,672,807) comes due Dec 13, 2026. Unpaid by Jun 14, 2027, it lapses early.
  • 1 fee due Jan 25, 2027
    The maintenance fee for (17-ß)-3-Oxoandrost-4-EN-17YL Tridecanoate Compositions and Methods of Their Preparation and Use (US 11,707,467) comes due Jan 25, 2027. Unpaid by Jul 26, 2027, it lapses early.
  • 1 fee due Jun 8, 2027
    The maintenance fee for High-Strength Testosterone Undecanoate Compositions (US 9,205,057) comes due Jun 8, 2027. Unpaid by Dec 8, 2027, it lapses early.
  • 1 fee due Jul 16, 2027
    The maintenance fee for Bioavailable Solid State (17-Beta)-Hydroxy-4-Androsten-3-One Esters (US 11,872,235) comes due Jul 16, 2027. Unpaid by Jan 18, 2028, it lapses early.
  • 1 fee due Aug 18, 2027
    The maintenance fee for Testosterone Undecanoate Compositions (US 10,561,615) comes due Aug 18, 2027. Unpaid by Feb 18, 2028, it lapses early.
  • 1 fee due Sep 19, 2027
    The maintenance fee for Oral (17-ß)-3-Oxoandrost-4-EN-17-YL Tridecanoate Therapy (US 11,931,367) comes due Sep 19, 2027. Unpaid by Mar 20, 2028, it lapses early.
  • 1 fee due Oct 30, 2027
    The maintenance fee for Oral Allopregnanolone Compositions and Methods of Use (US 11,969,434) comes due Oct 30, 2027. Unpaid by May 1, 2028, it lapses early.

Which patents, and when each one lapses · Pro

Recent changes

  • 1 of the patents on this record was granted since Aug 17, 2026

What they patent

The 5 largest of its 19 families, grouped by real patent family and labeled by the earliest filing in each. No technology classification is inferred from titles.

Patents held now

Soonest term end first.
PatentTitleStatusExpiresConfidence
US 8,778,922Steroidal Compositions
In force
 · High confidence
In forceHigh confidence
US 8,865,695Steroidal Compositions
In force
 · High confidence
In forceHigh confidence
US 11,052,096Steroidal Compositions
In force (reinstated)
 · High confidence
In force (reinstated)High confidence
US 11,304,960Steroidal Compositions
In force
 · High confidence
In forceHigh confidence
US 9,375,437Progesterone Containing Oral Dosage Forms and Kits
In force
 · High confidence
In forceHigh confidence
US 9,034,858High-Strength Testosterone Undecanoate Compositions
In force
 · High confidence
In forceHigh confidence
US 9,205,057High-Strength Testosterone Undecanoate Compositions
In force
 · High confidence
In forceHigh confidence
US 9,358,241High-Strength Testosterone Undecanoate Compositions
In force
 · High confidence
In forceHigh confidence
US 9,480,690High-Strength Testosterone Undecanoate Compositions
In force
 · Medium confidence
In forceMedium confidence
US 9,943,527High-Strength Testosterone Undecanoate Compositions
In force
 · Low confidence
In forceLow confidence
10 of 62 patents shown.
Pro members see all 62.
Pro members: see all 62 patents
Also on record, not counted in the 62: 10 patents ended · 10 applications pending · 100 applications abandoned. List them

Sources and methods

Compiled from USPTO application file histories, grants and recorded assignments, with the company's own names reviewed by hand. How this record was built
Portfolio grouped automatically from ownership conveyances to the names matched to this company, usually every name that begins with its own, so it counts patents an affiliate holds; each list row names the holder of record. Security interests are excluded and ambiguous records are not reviewed by hand.
Fee due within 90 days marks a patent with a maintenance fee due within 90 days of the date this page was computed and not yet recorded paid, so it can end earlier than the bar shows. A fee left unpaid ends the patent at the close of the six month grace period that follows its due date, not on the due date itself. It is not a prediction that the fee will be missed.
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 15, 2026 · includes USPTO assignment & status data published Nov 15, 2026 and grant & fee data published Nov 10, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited